Embryos expressing TorNIG.5092R under the control of Scer\GAL4kirre.PU show a significant reduction in the number of nuclei in the segmental border muscle.
Expression of TorNIG.5092R using Scer\GAL4nub-AC-62 results in abnormally small wings in which cell size is decreased.
Expression of TorNIG.5092R with Scer\GAL4ppl.PP causes the fusion of lipid vesicles in the fat body.
Expression of TorNIG.5092R under the control of Scer\GAL4Act5C.PP results in a significant reduction in fat-body cell size.
Scer\GAL4nub-AC-62, mTorNIG.5092R has abnormal size phenotype, enhanceable by Scer\GAL4nub-AC-62/hppyUAS.cMa
Scer\GAL4nub-AC-62, mTorNIG.5092R has decreased cell number phenotype, enhanceable by Scer\GAL4nub-AC-62/hppyUAS.cMa
Scer\GAL4nub-AC-62, mTorNIG.5092R has decreased cell size phenotype, enhanceable by Scer\GAL4nub-AC-62/hppyUAS.cMa
Scer\GAL4nub-AC-62/mTorNIG.5092R is an enhancer of abnormal size phenotype of Scer\GAL4nub-AC-62, hppyUAS.cMa
Scer\GAL4nub-AC-62/mTorNIG.5092R is an enhancer of decreased cell number phenotype of Scer\GAL4nub-AC-62, hppyUAS.cMa
Scer\GAL4nub-AC-62/mTorNIG.5092R is an enhancer of decreased cell size phenotype of Scer\GAL4nub-AC-62, hppyUAS.cMa
mTorNIG.5092R, Scer\GAL4FRT.Rnor\Cd2.Act5C is a suppressor of neoplasia phenotype of Ras85DV12.UAS, Scer\GAL4FRT.Rnor\Cd2.Act5C, dlg1GD4689
Scer\GAL4nub-AC-62, mTorNIG.5092R has wing phenotype, enhanceable by Scer\GAL4nub-AC-62/hppyUAS.cMa
Scer\GAL4nub-AC-62/mTorNIG.5092R is an enhancer of wing phenotype of Scer\GAL4nub-AC-62, hppyUAS.cMa
Co-expression of hppyScer\UAS.cMa and TorNIG.5092R using Scer\GAL4nub-AC-62 results in a strong synergistic phenotype of reduced wing size and reduced cell size and number.
Depletion of Tor, through expression of TorNIG.5092R, strongly reduces tumour size in Ras85DV12.Scer\UAS-dlg1GD4689 MARCM clones.